DCGI approves MSD India’s drug Keytruda for treatment of two additional cancer indications – ET HealthWorld | Pharma
New Delhi: MSD has received the Drug Controller General of India’s (DCGI) approval for Keytruda (pembrolizumab) in the treatment of…